ArticleNature communications2023

Nanomedicine-based co-delivery of a calcium channel inhibitor and a small molecule targeting CD47 for lung cancer immunotherapy.

Yuedong Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.